Immunosuppressive effect of prolactin-induced protein

Chemical Immunology and Allergy

Volumn 96, Issue , 2012, Pages 100-107

  Sugiura, S ^a   Fujimiya, M ^b   Ebise, H ^c   Miyahira, Y ^a   Kato, I ^d   Sugiura, Y ^e   Kimura, T ^c   Uehara, M ^f   Sato, H ^a   Sugiura, H ^a,g  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d HOKURIKU UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f Yasu Hospital   (Japan)

^g Sugiura Skin Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARGINYLTHREONYLVALYLTHREONYLPHENYLALANYLALANYLTHREONYLVALYLISOLEUCYLASPARTYLISOLEUCYLVALYLARGINYLGLUTAMYLLYSYLASPARAGINYLISOLEUCYLCYSTEINYLPROLYLASPARAGINYLASPARTYLMETHIONYLALAYLVALYLVALYLPROLYL; CD4 ANTIGEN; IMMUNOMODULATING AGENT; OXAZOLONE; UNCLASSIFIED DRUG; BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; PROLACTIN INDUCED PROTEIN; PROLACTIN INDUCED PROTEIN[106-132]; PROTEIN ANTIBODY; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNOHISTOLOGY; INFLAMMATION; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN CELL; THICKNESS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CLINICAL FEATURE; CONTACT SENSITIVITY; DOWN REGULATION; EAR EDEMA; EPIDERMIS CELL; EPIDERMIS HYPERPLASIA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE EFFECT; INFLAMMATORY INFILTRATE; MOUSE MODEL; PARAKERATOSIS; PROTEIN EXPRESSION; REPEATED DRUG DOSE;

ANIMALS; ANTIBODIES; ANTIGENS, CD4; BINDING SITES; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HLA-DR ANTIGENS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; KERATINOCYTES; MALE; MICE; MICE, INBRED C57BL; OXAZOLONE; PROTEINS;

EID: 84859207992     PISSN: 16602242     EISSN: 16622898     Source Type: Book Series    
DOI: 10.1159/000331895     Document Type: Article

References (14)

1. Murphy LC, Tsuyuki D, Myal Y, et al: Isolation and sequencing of a cDNA clone for a prolactininducible protein (PIP). J Biol Chem 1987;262: 15236.
2. Haagensen DE Jr, Gall SA, Brazy JE, et al: Analysis of amniotic fluid, maternal plasma, and cord blood for a human breast gross cystic disease fluid protein. Am J Obstet Gynecol 1980;138:25-32.
3. Sanchez LM, Vizoso F, Diez-Itza I, et al: Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 1992;52:95-100.
4. Gaubin M, Autiero M, Basmaciogullari S, et al: Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells. J Immunol 1999;162:2631-2638.
5. Autiero M, Abrescia P, Guardiola J: Interaction of seminal plasma proteins with cell surface antigens: Presence of a CD4-binding glycoprotein in human seminal plasma. Exp Cell Res 1991;197:268-271.
6. Autiero M, Houlgatte R, Martin M, et al: Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4. Int Immunol 1995;7:191-197.
7. Basmaciogullari S, Autiero M, Culerrier R, et al: Mapping the CD4 binding domain of gp17, a glycoprotein secreted from seminal vesicles and breast carcinomas. Biochemistry 2000;39:5332-5340.
8. Lynch GW, Slaytor EK, Elliott FD, et al: CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Exp Dermatol 2003;12: 700-711.
9. Albanesi C, Cavani A, Girolomoni G: Interferon-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J Invest Dermatol 1998;110: 138-142.
10. Myal Y, Iwasiow B, Yarmill A, et al: Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene. Endocrinology 1994;135:1605-1610.
11. Nagata K, Fujimiya M, Sugiura H, Uehara M: Intracellular localization of serotonin in mast cells of the colon in normal and colitis rats. Histochem J 2001;33:559-568.
12. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 1995;57:289-300.
13. Lee B, Bowden GH, Myal Y: Identification of mouse submaxillary gland protein in mouse saliva and its binding to mouse oral bacteria. Arch Oral Biol 2002; 47:327-332.
14. Yu-Lee LY: Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res 2002;57:435-455.